Healthy China International Biotechnology

Healthy China International Biotechnology is a life sciences company focused on the development and commercialization of regenerative medicine and cellular therapies. Based in Shenzhen, China, the company operates high-standard facilities for the cryopreservation and management of stem cells and immune cells, serving as a comprehensive 'life bank' for individuals. Their research pipeline includes therapies derived from mesenchymal stem cells (MSCs) and Natural Killer (NK) cells, aimed at addressing aging-related decline and chronic health conditions. Healthy China International Biotechnology integrates biotechnology research with clinical application to provide personalized health management solutions. The company plays an active role in the regional expansion of China’s biotechnology sector under the 'Healthy China 2030' national strategy.